WESTBURY, N.Y., May 6, 2014 /PRNewswire/ — Vasomedical, Inc. (OTC BB: VASO) announced today that it will release its financial results for the three months ended March 31, 2014 on Wednesday, May 14, 2014, before markets open. The Company will host a conference call on Wednesday, May 14th at 10:00 a.m. ET featuring remarks by...
Read More

WESTBURY, N.Y., April 16, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”... (OTC BB: VASO..., a diversified medical technology company specializing in the design, manufacture and sale of medical devices, including EECP® Therapy systems, the gold standard of ECP therapy, today announced that it has entered into an agreement with Chongqing PSK-Health Sci-Tech Development Co., Ltd. (“PSK”...
Read More

WESTBURY, N.Y., March 27, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months and year ended December 31, 2013. “Our equipment segment, which includes EECP® and Biox™ products, showed momentum in the last quarter of 2013 with equipment sales up by 26% for the quarter, and, as...
Read More

WESTBURY, N.Y., March 21, 2014 /PRNewswire/ — Vasomedical, Inc. (OTC BB: VASO) announced today that it will release its financial results for the three months ended and year ended December 31, 2013 on Thursday, March 27, 2014. The Company will host a conference call on Thursday, March 27th at 10:00 a.m. ET featuring remarks by...
Read More

WESTBURY, N.Y., March 17, 2014 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, including EECP® Therapy systems, the gold standard of ECP therapy, today announced that its wholly owned subsidiary Biox Instruments Co. Ltd., based in Wuxi, China, has received approval...
Read More